Go Pro

Novanta Inc. $NOVT Shares Bought by Bank of America Corp DE

Novanta logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Bank of America increased its Novanta stake by 18.3% in the first quarter, adding 70,728 shares to own 456,241 shares valued at approximately $53.9 million. Institutional investors collectively hold 98.35% of the company.
  • Novanta exceeded quarterly expectations, reporting $0.89 in EPS and $265.81 million in revenue, with revenue up 10.3% year over year. The company issued fiscal 2026 EPS guidance of $3.68–$3.74.
  • Shares opened at $167.71 after rising 2.3%, while analysts maintain an overall “Hold” rating with a $194 consensus price target. CEO Matthijs Glastra sold 6,500 shares under a pre-arranged Rule 10b5-1 plan.
  • Five stocks to consider instead of Novanta.

Bank of America Corp DE increased its stake in Novanta Inc. (NASDAQ:NOVT - Free Report) by 18.3% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 456,241 shares of the technology company's stock after acquiring an additional 70,728 shares during the period. Bank of America Corp DE owned approximately 1.28% of Novanta worth $53,887,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the stock. Danske Bank A S acquired a new stake in Novanta in the third quarter worth approximately $40,000. Allworth Financial LP increased its position in shares of Novanta by 978.4% during the 4th quarter. Allworth Financial LP now owns 399 shares of the technology company's stock valued at $47,000 after purchasing an additional 362 shares during the period. EverSource Wealth Advisors LLC increased its position in shares of Novanta by 120.1% during the 4th quarter. EverSource Wealth Advisors LLC now owns 427 shares of the technology company's stock valued at $51,000 after purchasing an additional 233 shares during the period. ANTIPODES PARTNERS Ltd acquired a new position in shares of Novanta during the 4th quarter valued at $53,000. Finally, Farther Finance Advisors LLC raised its stake in shares of Novanta by 1,291.4% in the 4th quarter. Farther Finance Advisors LLC now owns 487 shares of the technology company's stock worth $58,000 after buying an additional 452 shares in the last quarter. Institutional investors and hedge funds own 98.35% of the company's stock.

Insider Buying and Selling at Novanta

In other news, CEO Matthijs Glastra sold 6,500 shares of Novanta stock in a transaction that occurred on Thursday, July 2nd. The shares were sold at an average price of $161.13, for a total value of $1,047,345.00. Following the transaction, the chief executive officer directly owned 29,761 shares of the company's stock, valued at $4,795,389.93. This trade represents a 17.93% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.20% of the stock is currently owned by company insiders.

Novanta Trading Up 2.3%

Shares of NASDAQ NOVT opened at $167.71 on Wednesday. The company has a quick ratio of 3.79, a current ratio of 4.57 and a debt-to-equity ratio of 0.12. Novanta Inc. has a 12 month low of $98.27 and a 12 month high of $176.38. The company has a market cap of $6.34 billion, a price-to-earnings ratio of 107.51 and a beta of 1.68. The business has a fifty day simple moving average of $154.07 and a 200-day simple moving average of $142.06.

Novanta (NASDAQ:NOVT - Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The technology company reported $0.89 earnings per share for the quarter, topping analysts' consensus estimates of $0.83 by $0.06. The firm had revenue of $265.81 million for the quarter, compared to analysts' expectations of $262.30 million. Novanta had a return on equity of 10.83% and a net margin of 6.00%.Novanta's revenue was up 10.3% on a year-over-year basis. During the same quarter last year, the business posted $0.76 EPS. Novanta has set its FY 2026 guidance at 3.680-3.740 EPS and its Q3 2026 guidance at 0.950-1.000 EPS. Sell-side analysts predict that Novanta Inc. will post 3.7 EPS for the current year.

Analyst Ratings Changes

Several analysts have recently weighed in on NOVT shares. Robert W. Baird set a $194.00 price objective on Novanta in a report on Friday. Wall Street Zen upgraded shares of Novanta from a "hold" rating to a "buy" rating in a research report on Sunday. Finally, Weiss Ratings reiterated a "hold (c-)" rating on shares of Novanta in a report on Wednesday, July 15th. One investment analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company's stock. According to data from MarketBeat.com, Novanta presently has an average rating of "Hold" and a consensus target price of $194.00.

View Our Latest Stock Analysis on NOVT

Novanta Profile

(Free Report)

Novanta, Inc NASDAQ: NOVT is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta's product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta's Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.

Further Reading

Want to see what other hedge funds are holding NOVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Novanta Inc. (NASDAQ:NOVT - Free Report).

Institutional Ownership by Quarter for Novanta (NASDAQ:NOVT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Novanta Right Now?

Before you consider Novanta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novanta wasn't on the list.

While Novanta currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own - Summer 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines